Gsk does not expect fda approval of hpv vaccine cervarix until end of 2009
GlaxoSmithKline on Monday said it does not expect to receive FDA approval for its human papillomavirus vaccine Cervarix until late 2009, Reuters reports. GSK said it has decided to wait until results from a Phase III trial of the vaccine are available before seeking U.S. approval. (Source: Health News from Medical News Today)
This digital document is an article from Family Practice News, published by International Medical News Group on September 1, 2003. The length of the article is 626 words. The page length shown above